EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor-associated macrophage-based predictive and prognostic model for hepatocellular carcinoma

Changquan Shang, Tiancong He, Yi Zhang iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0325120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Changquan Shang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tumor-Associated Macrophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a prevalent malignancy influenced by the interplay between the immune system and tumor progression, but the detailed biological mechanism still elusive. To address this, we integrate single-cell RNA sequencing (scRNAseq) data with bulk sequencing data to investigate the prognostic significance of tumor-associated macrophages (TAMs) signatures in HCC. Utilizing bioinformatics approaches, including differential gene expression analysis, Cox regression, and logistic regression modeling, we constructed a robust prognostic model that effectively stratifies HCC patients into distinct risk groups with significant differences in survival outcomes. Applying our model to multiple HCC cohorts, robust predictive and prognostic performances were observed. Moreover, examination of the tumor microenvironment (TME) revealed distinct patterns of immune cell infiltration between high-risk and low-risk patient groups, which may contribute to the poorer outcomes observed in high-risk patients. Finally, drug sensitivity and AutoDock simulations suggest that the signature genes we identified could be potential targets for HCC therapy. In summary, this study provides novel insights into the HCC tumor microenvironment and its interaction with TAMs, offering a prognostic model with potential for improving patient stratification and guiding the development of novel therapeutic approaches. Future research ought to concentrate on confirming our findings in larger, prospective studies and examining the functional implications of TAMs in HCC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTumor-Associated MacrophagesHumansPrognosisTumor MicroenvironmentGene Expression Regulation, NeoplasticMaleFemaleBiomarkers, Tumor

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgical Oncology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, China.

ORCID-Profile: Yi Zhang

Zitieren

APA

Shang, C., He, T., & Zhang, Y. (2025). Tumor-associated macrophage-based predictive and prognostic model for hepatocellular carcinoma. PLOS One. https://doi.org/10.1371/journal.pone.0325120

Vancouver

Shang C, He T, Zhang Y. Tumor-associated macrophage-based predictive and prognostic model for hepatocellular carcinoma. PLOS One. 2025. doi:10.1371/journal.pone.0325120

BibTeX
@article{Shang2025,
  author = {Shang, Changquan and He, Tiancong and Zhang, Yi},
  title = {Tumor-associated macrophage-based predictive and prognostic model for hepatocellular carcinoma},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325120}
}
Kostenlos starten →